Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:49 AM
Ignite Modification Date:
2025-12-25 @ 4:49 AM
NCT ID:
NCT02402218
Eligibility Criteria:
Inclusion Criteria:
* 18 years old or greater
* Hepatitis C genotype 1 infection for at least 6 months
* No evidence of Hepatocellular Carcinoma or End-Stage Liver Disease (e.g., history of ascites, bleeding varices, and/or encephalopathy)
* Cluster of Differentiation 4 (CD4) cell count \> 100 cells/mm3 for more than 3 months
* HIV RNA positive for more than 3 months
* Ability to communicate effectively with key study personnel
* Willing to give written informed consent and comply with the study requirements
* Life expectancy \> 2 year
Exclusion Criteria:
* Currently receiving Hepatitis C treatment
* Renal insufficiency - estimated glomerular filtration rate, calculated by the chronic kidney disease epidemiology collaboration formula: \<30 mL/min/1.73 m2
* Antiretroviral therapy inclusive of STRIBILD or APTIVUS
* Inability or unwillingness to avoid pregnancy for woman of child-bearing potential and/or to father children during treatment and for a period of 3 months following completion
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02402218
Study Brief:
Protocol Section:
NCT02402218